Cargando…
Supportive Care in Hematology
Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatm...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153764/ http://dx.doi.org/10.1007/978-1-59745-149-9_3 |
_version_ | 1783521706471587840 |
---|---|
author | Hiemenz, John Munker, Reinhold |
author_facet | Hiemenz, John Munker, Reinhold |
author_sort | Hiemenz, John |
collection | PubMed |
description | Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatment regimens that generally further decrease the patient’s resistance to infections. An intensive transfusion support with platelets, red cell concentrates, immunoglobulins, cytokines, and other drugs is necessary. Many patients also need antiemetic agents, nutritional support, pain medication, and, very often, venous catheters. All of these measures are considered supportive care and apply in a similar fashion to the high-dose treatment of solid tumors. Supportive care measures, along with the treatment and prophylaxis of infections, are discussed in this chapter. Transfusion support is discussed in Chapter 22. |
format | Online Article Text |
id | pubmed-7153764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71537642020-04-14 Supportive Care in Hematology Hiemenz, John Munker, Reinhold Modern Hematology Article Patients with hematological malignancies such as leukemias and lymphomas are predisposed to a wide spectrum of infections that need special attention. These patients are immunosuppressed not only as a result of the immune defects associated with the underlying disease, but also because of the treatment regimens that generally further decrease the patient’s resistance to infections. An intensive transfusion support with platelets, red cell concentrates, immunoglobulins, cytokines, and other drugs is necessary. Many patients also need antiemetic agents, nutritional support, pain medication, and, very often, venous catheters. All of these measures are considered supportive care and apply in a similar fashion to the high-dose treatment of solid tumors. Supportive care measures, along with the treatment and prophylaxis of infections, are discussed in this chapter. Transfusion support is discussed in Chapter 22. 2007 /pmc/articles/PMC7153764/ http://dx.doi.org/10.1007/978-1-59745-149-9_3 Text en © Humana Press Inc., Totowa, NJ 2007 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Hiemenz, John Munker, Reinhold Supportive Care in Hematology |
title | Supportive Care in Hematology |
title_full | Supportive Care in Hematology |
title_fullStr | Supportive Care in Hematology |
title_full_unstemmed | Supportive Care in Hematology |
title_short | Supportive Care in Hematology |
title_sort | supportive care in hematology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153764/ http://dx.doi.org/10.1007/978-1-59745-149-9_3 |
work_keys_str_mv | AT hiemenzjohn supportivecareinhematology AT munkerreinhold supportivecareinhematology |